Latest Articles
Virtual-First Quaternary Endometriosis Care Program Launches in California - FinancialContent
Virtual-First Quaternary Endometriosis Care Program Launches in California FinancialContent
Published: Jan. 6, 2026, 7:51 a.m.
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles - The i Paper
I spent £10,000 to treat my endometriosis – we don’t need more NHS hurdles The i Paper
Published: Jan. 6, 2026, 6 a.m.
Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment - geneonline.com
Study Explores Role of Fibrosis in Impaired Ovarian Function and Potential Use of Pirfenidone for Endometriosis Treatment geneonline.com
Published: Jan. 5, 2026, 9:43 p.m.
Menopause and endometriosis are among the conditions the NHS’s new ‘online hospital’ will focus on - Stylist
Menopause and endometriosis are among the conditions the NHS’s new ‘online hospital’ will focus on Stylist
Published: Jan. 5, 2026, 9:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - BIOENGINEER.ORG
Pirfenidone’s Promise for Ovarian Endometriosis Treatment BIOENGINEER.ORG
Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - Bioengineer.org
Pirfenidone’s Promise for Ovarian Endometriosis Treatment Bioengineer.org
Published: Jan. 5, 2026, 8:34 p.m.
Pirfenidone’s Promise for Ovarian Endometriosis Treatment - bioengineer.org
Pirfenidone’s Promise for Ovarian Endometriosis Treatment bioengineer.org
Published: Jan. 5, 2026, 8:34 p.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology
Published: Jan. 5, 2026, 1:07 p.m.
Link copied to clipboard!